Use of multiple metrics to assess antibiotic use in Italian children's hospitals.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 02 2021
Historique:
received: 17 09 2020
accepted: 25 01 2021
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 16 11 2021
Statut: epublish

Résumé

Quantification of antibiotic utilization is an essential component of antibiotic stewardship programs. In this multicentric study, we used different metrics to evaluate inpatient antibiotic use in children. The study objectives were to describe point prevalence of antibiotic use by indication and patient characteristics, to evaluate DOTs, LOTs and PDDs, and to compare PDDs to DDDs, which assume average maintenance dose per day in adults. All children hospitalized on the days of the study were included. Trained personnel collected demographic and clinical data from patients' clinical records. We recorded information about antibiotics administered on the date of data collection, and in the previous 30 days of hospitalization. Of 810 patients, 380 (46.9%; CI 95%: 43.4-50.4) received one or more antibiotics; prevalence of use was 27.0% for prophylaxis (219/810), and 20.7% (168/810) for treatment. Overall, 587 drugs were issued to the 380 patients receiving antibiotics (1.5 antibiotic per patient). When considering treatments, DOT and LOT per 100 patient-days were 30.5 and 19.1, respectively, resulting in a DOT/LOT ratio of 1.6. PDDs increased with age and approached DDDs only in children aged ≥ 10 years; the ratio between PDDs estimated in children aged ≥ 10 years and in 0-11 month-old infants ranged from 2 for sulfamethoxazole and trimethoprim, to 25 for meropenem. Our results confirm that DOT, LOT and PDD are better alternatives to DDD in children.

Identifiants

pubmed: 33574450
doi: 10.1038/s41598-021-83026-1
pii: 10.1038/s41598-021-83026-1
pmc: PMC7878731
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3543

Références

Can J Infect Dis. 2004 Jan;15(1):29-35
pubmed: 18159441
Antimicrob Resist Infect Control. 2013 Nov 18;2:31
pubmed: 24237856
BMJ Open. 2016 Nov 3;6(11):e012675
pubmed: 27810974
BMJ. 2007 Sep 1;335(7617):429
pubmed: 17656505
Circulation. 2000 Jun 27;101(25):2916-21
pubmed: 10869263
Eur J Pediatr. 2018 Aug;177(8):1271-1278
pubmed: 29948254
Pediatr Infect Dis J. 2013 Jun;32(6):e242-53
pubmed: 23838740
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
J Antimicrob Chemother. 2010 Oct;65(10):2247-52
pubmed: 20713405
J Antimicrob Chemother. 2016 Apr;71(4):1106-17
pubmed: 26747104
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):1-6
pubmed: 23884866
J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi50-vi58
pubmed: 29878222
Clin Microbiol Rev. 2013 Apr;26(2):289-307
pubmed: 23554418
Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1301-3
pubmed: 20556467
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Infection. 2009 Aug;37(4):349-52
pubmed: 19277464

Auteurs

Carmen D'Amore (C)

Clinical Pathways and Epidemiology Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Marta Luisa Ciofi Degli Atti (ML)

Clinical Pathways and Epidemiology Unit, Bambino Gesù Children's Hospital, Rome, Italy. marta.ciofidegliatti@opbg.net.

Carla Zotti (C)

Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

Rosa Prato (R)

Department of Medical and Surgical Sciences, University of Foggia, Ospedale "D'Avanzo" Policlinico Riuniti, Foggia, Italy.

Giuliano Guareschi (G)

Ospedale Infantile Regina Margherita - AOU Città Della Salute E Della Scienza Di Torino, Torino, Italy.

Raffaele Spiazzi (R)

Ospedale dei Bambini - ASST Degli Spedali Civili di Brescia, Brescia, Italy.

Gaetano Petitti (G)

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Ospedale Pediatrico "Giovanni XXIII", Bari, Italy.

Maria Luisa Moro (ML)

Regional Health and Social Agency, Emilia-Romagna Region, Italy.

Massimiliano Raponi (M)

Medical Direction, Bambino Gesù Children's Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH